natgillin/translations-raw huggingface dataset:
Docetaxel Winthrop концентрат за инфузионен разтвор е бледожълт до кафеникавожълт разтвор.
Docetaxel Winthrop concentrate for solution for infusion is a pale yellow to brownish-yellow solution.
Docetaxel Winthrop може да се използва самостоятелно след неуспех на други лечения.
Docetaxel Winthrop can be used on its own after other treatments have failed.
Docetaxel Winthrop не трябва да се прилага при пациенти, при които броят на неутрофилите е по-малък от 1500 клетки/mm3 или с тежки чернодробни проблеми.
Docetaxel Winthrop must not be used in patients who have a neutrophil count of less than 1,500 cells/mm3 or who have severe problems with their liver.
Docetaxel Winthrop не трябва да се прилага при хора, които са свръхчувствителни (алергични) към доцетаксел или към някоя от останалите съставки.
Docetaxel Winthrop must not be used in people who are hypersensitive (allergic) to docetaxel or any of the other ingredients.
Docetaxel Winthrop се използва с цисплатин и 5-флуороурацил (други противоракови лекарства); рак на главата и шията при пациенти, при които ракът е локално напреднал (разраснал се е, но не е започнал е да се разпространява).
Docetaxel Winthrop is used with cisplatin and 5-fluorouracil (other anticancer medicines); head and neck cancer in patients whose cancer is locally advanced (a cancer that has grown but has not spread).
Docetaxel Winthrop се използва само когато броят на неутрофилите (нивото на вид бели кръвни клетки в кръвта) е в рамките на нормалните стойности (поне 1500 клетки/mm3).
Docetaxel Winthrop is only used when the neutrophil count (the level of a type of white blood cell in the blood) is normal (at least 1,500 cells/mm3).
Docetaxel Winthrop се използва се с цисплатин и 5- флуороурацил.
Docetaxel Winthrop is used with cisplatin and 5-fluorouracil.
Docetaxel Winthrop се прилага като инфузия с продължителност един час на всеки три седмици.
Docetaxel Winthrop is given as a one-hour infusion every three weeks.
Docetaxel Winthrop се прилага при лечение на следните типове рак:
Docetaxel Winthrop is used to treat the following types of cancer:
Docetaxel Winthrop съдържа алкохол.
Docetaxel Winthrop contains alcohol.
Docetaxel Winthrop съдържа етанол (алкохол)
Docetaxel Winthrop contains ethanol (alcohol)
Docetaxel Winthrop ще Ви бъде приложен от медицински специалист.
Docetaxel Winthrop will be administered to you by a healthcare professional.
Docetaxel Winthrop ще Ви бъде приложен чрез инфузия в някоя от венитe (интравенозно приложение).
Docetaxel Winthrop will be given by infusion into one of your veins (intravenous use).
Docetaxel действа и на нераковите клетки, например на кръвните клетки, което може да причини нежелани реакции.
Docetaxel also affects non cancer cells such as blood cells, which can cause side effects.
Dock kan dessa reaktioner bli mer uttalade och/eller pågå längre.
However, these reactions may be more severe and/or last longer.
DODATEK I
ANNEX I
Dodatna zdravila:
Additional medicines:
Dodatne informacije
Further information
DODATNE INFORMACIJE Kaj vsebuje zdravilo PhotoBarr
FURTHER INFORMATION What PhotoBarr contains
Dodatne informacije o ravnanju z zdravilom Zoledronska kislina Actavis, vključno z navodili za pripravo nižjih odmerkov, so navedene v poglavju 4.2.
Additional information on handling of Zoledronic acid Actavis, including guidance on preparation of reduced doses, is provided in section 4.2.
Dodatni neželeni učinki, povezani z uporabo zdravil, ki vsebujejo pravastatin ali fenofibrat, ki so jih opazili v kliničnih študijah in pri izkušnjah z zdravilom po začetku trženja in do katerih lahko pride pri uporabi zdravila Pravafenix, so našteti spodaj.
Additional adverse reactions associated with the use of medicinal products containing pravastatin or fenofibrate observed in clinical trials and post- marketing experience that may potentially occur with Pravafenix are listed below.
Dodatni ukrepi za zmanjševanje tveganj
Additional risk minimisation measures
Dodatni ukrepi za zmanjševanje tveganj
At the request of the European Medicines Agency,
Dodatno so učinkovitost ustekinumaba in etanercepta primerjali v randomizirani, dvojno slepi, z učinkovino nadzorovani študiji pri bolnikih z zmerno do hudo psoriazo s plaki, ki se na zdravljenje s ciklosporinom, MTX ali PUVA niso odzvali v zadostni meri, ga niso prenašali ali je bilo le-to kontraindicirano.
In addition, a randomised, blinded assessor, active-controlled study compared ustekinumab and etanercept in patients with moderate to severe plaque psoriasis who had had an inadequate response to, intolerance to, or contraindication to ciclosporin, MTX, or PUVA.
Dodržujte reálné cílové hodnoty kalorií a tuků, protože to je dobrý způsob jak si dlouhodobě udržet dosažené snížení Vaší tělesné hmotnosti.
Stick to realistic calorie and fat targets as this is a good way of maintaining your weight loss achievements in the long-term.
Dodržujte reálné cílové hodnoty kalorií a tuků, protože to je dobrý způsob, jak si dlouhodobě udržet dosažené snížení Vaší tělesné hmotnosti.
Stick to realistic calorie and fat targets as this is a good way of maintaining your weight loss achievements in the long-term.
Dogodek*
Event
Dogodek**
Event
Dojenje
Breast-feeding
Dojenje
Breastfeeding
Dojenje
Lactation
Dojenje (glejte poglavje 4.6)
Breast-feeding (see section 4.6)
Dojenje je treba med zdravljenjem s pemetreksedom prekiniti (glejte poglavje 4.3).
Breast-feeding must be discontinued during pemetrexed therapy (see section 4.3).
Dojenje morate med zdravljenjem s pemetreksedom prekiniti.
Breast-feeding must be discontinued during pemetrexed treatment.
Dojčenie
Breast-feeding
Dojčenie (pozri časť 4.6)
Breast-feeding (see section 4.6)
Dojčenie je kontraindikované počas liečby a 3 mesiace po nej (pozri časť 4.3).
Breast-feeding is contraindicated during treatment and 3 months thereafter (see section 4.3).
Dokazano je tudi, da kombinacija fibratov in statinov sinergijsko krepi transkripcijske dejavnosti receptorjev PPAR.
Fibrates and statins in combination have also been shown to synergistically increase the transcriptional activities of PPAR receptors.
Dokud nejsou pacienti obeznámeni se svou reakcí na léčbu přípravkem Intuniv, nemají manipulovat s těžkými předměty, řídit motorové vozidlo ani kolo (viz bod 4.7).
Patients are advised against operating heavy equipment, driving or cycling until they know how they respond to treatment with Intuniv (see section 4.7).
Dolasetron 100 miligramov (n = 191)
Dolasetron 100 milligrams (n= 191)
Dolgotrajno zdravljenje z zdravilom STELARA ne zavira humoralnega imunskega odziva na pnevmokokne polisaharide ali cepivo proti tetanusu (glejte poglavje 5.1).
Long term treatment with STELARA does not suppress the humoral immune response to pneumococcal polysaccharide or tetanus vaccines (see section 5.1).
Dolžina difuzorja (cm)
Diffuser length (cm)
Dolžina odprtine za balon (cm)
Balloon Window Length (cm)
Dolžina sluznice zdravljenega Barrettovega požiralnika (cm)
Treated Barrett's Mucosa Length (cm)
Domaniewska 39
02-672 Warszawa
Domaniewska 50 C 02-672 Warszawa Полша
Domaniewska 50 C 02-672 Warszawa Poland
Domaniewska 50 C PL-02-672 Warszawa Tel: + 48 22 549 15 00
Domaniewska 50 C PL - 02-672 Warszawa Phone: +48 22 549 15 00
Dopad poruchy funkce jater na farmakokinetiku guanfacinu u pediatrických pacientů (dětí a dospívajících ve věku 6–17 let) nebyl hodnocen.
The impact of hepatic impairment on the pharmacokinetics of guanfacine in paediatric patients (children and adolescents 6-17 years old) was not assessed.
Dopad poruchy funkce ledvin na farmakokinetiku guanfacinu u pediatrických pacientů (dětí a dospívajících ve věku 6–17 let) nebyl hodnocen.
The impact of renal impairment on the pharmacokinetics of guanfacine in paediatric patients (children and adolescents 6-17 years old) was not assessed.
dopoledne (atazanavir 300 mg
(atazanavir 300 mg once daily with
Doporučená dávka alli je jedna 27 mg tableta užívaná třikrát denně.
The recommended dose of alli is one 27 mg tablet to be taken three times daily.
Doporučená dávka alli je jedna 60 mg tobolka užívaná třikrát denně.
The recommended dose of alli is one 60 mg capsule to be taken three times daily.
Doporučená dávka je od 0,05 až do 0,12 mg na kg tělesné hmotnosti denně.
The recommended dose is between 0.05 up to 0.12 mg per kg of bodyweight per day.
Doporučená dávka přípravku EVOTAZ je jedna tableta jednou denně perorálně spolu s jídlem (viz bod 5.2).
The recommended dose of EVOTAZ is one tablet once daily taken orally with food (see section 5.2).
Doporučená titrace dávky u dětí a dospívajících je uvedena níže (viz tabulky 1 a 2).
The recommended dose titration for children and adolescents is provided below (see tables 1 and 2).
Doporučené dávkování kolchicinu podávaného s přípravkem EVOTAZ u pacientů s poruchou funkce ledvin nebo jater: u pacientů s normální funkcí ledvin nebo jater, u kterých je požadována léčba přípravkem EVOTAZ, je doporučeno snížení dávky či přerušení podávání kolchicinu.
Recommended dosage of colchicine when administered with EVOTAZ in patients without renal or hepatic impairment: a dose reduction in colchicine dosage or an interruption of colchicine treatment is recommended in patients with normal renal or hepatic function if treatment with EVOTAZ is required.
Doporučení při souběžném podávání
Recommendations concerning co- administration
Doporučení při vynechání dávky
Advice on missed doses
Doporučení vydaná pro souběžné užívání atazanaviru a jiných léčivých přípravků se tedy může lišit v závislosti na tom, zda atazanavir je posilován ritonavirem nebo kobicistatem.
The recommendations given for concomitant use of atazanavir and other medicinal products may, therefore, differ depending on whether atazanavir is boosted with ritonavir or cobicistat.
Doporučuje se klinické a laboratorní sledování s ohledem na hyperbilirubinemii.
Clinical and laboratory monitoring for hyperbilirubinaemia is recommended.
Doporučuje se použití jiného antikoagulancia, které není ovlivněno inhibicí nebo indukcí CYP (např. prasugrel) (viz bod 4.3).
Use of other antiplatelets not affected by CYP inhibition or induction (e.g. prasugrel) is recommended (see section 4.3).
Doporučuje se sledování INR (International Normalized Ratio).
It is recommended that the INR (International Normalized Ratio) be monitored.
Doporučuje se začít s programem diety a cvičení ještě před začátkem léčby alli.
It is recommended that a diet and exercise programme is started before beginning treatment with alli.
Doporučuje se zvážit jinou (nehormonální) spolehlivou metodu antikoncepce.
An alternate (non- hormonal) reliable method of contraception is recommended.
doporučuje u pacientů, kteří
recommended for patients in whom
Doribax 250 mg прах за инфузионен разтвор
Doribax 250 mg powder for solution for infusion
Doribax 250 mg прах за инфузионен разтвор дорипенем
Doribax 250 mg powder for solution for infusion doripenem
Doribax 250 mg прах за инфузионен разтвор дорипенем (doripenem)
Doribax 250 mg powder for solution for infusion doripenem
Doribax 250 mg прах за инфузия дорипенем
Doribax 250 mg powder for infusion doripenem
Doribax 500 mg прах за инфузионен разтвор
Doribax 500 mg powder for solution for infusion
Doribax 500 mg прах за инфузионен разтвор дорипенем
Doribax 500 mg powder for infusion doripenem
Doribax 500 mg прах за инфузионен разтвор дорипенем
Doribax 500 mg powder for solution for infusion doripenem
Doribax 500 mg прах за инфузионен разтвор дорипенем (doripenem)
Doribax 500 mg powder for solution for infusion doripenem
Doribax е бял до леко жълтеникав, почти бял кристален прах в стъклен флакон.
Doribax is a white to slightly yellowish off-white crystalline powder in a glass vial.
Doribax е показан за лечение на следните инфекции при възрастни (вж. точка 4.4 и 5.1):
Doribax is indicated for the treatment of the following infections in adults (see sections 4.4 and 5.1):
Doribax е проучен в пет основни проучвания, които сравняват Doribax с други антибиотици:
Doribax has been studied in five main studies that compared Doribax with other antibiotics:
Doribax се използва за лечение на следните инфекции при възрастни:
Doribax is used to treat adults for the following infections:
Doribax ще бъде приготвен и ще Ви бъде приложен от лекар или медицинска сестра чрез интравенозна инфузия в продължение на един или четири часа в една от вените Ви (това понякога се нарича капково вливане).
Doribax will be prepared and given to you by a doctor or nurse over one or four hours as an intravenous infusion into one of your veins (this is sometimes known as a “drip”).
DORв в мозъка (n) Медиана (месеци) (95% CI)г
DORc in brain (n) Median (months) (95% CI)d
Dos emtricitabin
Emtricitabine dose (mg)
Dos och administreringssätt
Amounts to be administered and administration route
Dosage
Number
Dosen eller dosintervallet måste justeras hos alla patienter med kreatininclearance < 30 ml/min (se avsnitt 4.2, 4.4 och 5.2).
Dose or dose interval adjustment is required in all patients with creatinine clearance < 30 ml/min (see sections 4.2, 4.4 and 5.2).
Dosen eller dosintervallet måste justeras hos alla patienter med kreatininclearance < 30 ml/min (se avsnitt 4.4).
Dose or dose interval adjustment is required in all patients with creatinine clearance < 30 ml/min (see section 4.4).
Dosen ska justeras när kreatininclearance (CrCL) är ≤ 50 ml/min, enligt tabell 3 och 4 (se avsnitt 5.2).
The dose should be adjusted when creatinine clearance (CrCL) is ≤ 50 ml/min, as shown in Tables 3 and 4 (see section 5.2).
Dosering
How much to use
Dosering
Posology
Dosering bör ske med stor noggrannhet.
Particular care should be taken with regard to the accuracy of dosing.
DOSERING FOR HVER DYREART, ANVENDELSESMÅDE OG INDGIVELSESVEJ
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
DOSERING FOR HVER DYREART, ANVENDELSESMÅDE OG INDGIVELSESVEJ(E)
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
DOSERING FÖR VARJE DJURSLAG, ADMINISTRERINGSSÄTT OCH ADMINISTRERINGSVÄG
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
DOSERING FÖR VARJE DJURSLAG, ADMINISTRERINGSSÄTT OCH ADMINISTRERINGSVÄG
DOSAGE FOR EACH SPECIES, ROUTES AND METHOD OF ADMINISTRATION
DOSERING FÖR VARJE DJURSLAG, ADMINISTRERINGSSÄTT OCH ADMINISTRERINGSVÄG(AR)
DOSE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
Dosering för varje djurslag
Dosage for each species
Dosering och administreringssätt
Posology and method of administration
Dosering och behandlingsschema:
Dose and treatment schedule:
Dosering og indgivelsesvej
Amounts to be administered and administration route
Dosering:
Amounts to be administered:
Doseringb
time
Doseringer over 0,8 mg/kg/dag er ikke blevet evalueret i sikkerhedsstudier eller kontrollerede kliniske studier med måldyret.
Doses greater than 0.8 mg/kg/day have not been evaluated in the target animal safety or controlled clinical studies.
Doseringssprutan har markeringar motsvarande den volym som ska ges.
The syringe has a scale which corresponds to the volume required.
Doseringssprutan sätts ovanpå flaskan och har 2ml-markeringar.
The syringe fits onto the bottle and has a 2 ml scale.
Doseringssprutan sätts ovanpå flaskan och har kg-kroppsviktmarkeringar motsvarande underhållsdosering (dvs.
The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e.
Doseringsstyrka (mg)
Dosage strength (mg)
Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions.
Dosimetry in isolation perfusion of the limbs by assessments of perfused tissue volume and grading of toxic tissue reactions.
Dosjusteringar av Zinforo är inte nödvändiga hos äldre patienter med kreatininclearance över 50 ml/min.
Zinforo dose adjustment is not required in elderly patients with creatinine clearance above 50 ml/min.
Dosjusteringar krävs för barn från 2 månaders ålder till < 12 år och för ungdomar från 12 till < 18 år med kroppsvikt < 33 kg (se avsnitt 4.2).
Dose adjustments are required for children aged from 2 months to < 12 years and for adolescents aged 12 to < 18 years with bodyweight < 33 kg (see section 4.2).
Dosjusteringar krävs för vuxna, ungdomar och barn med CrCL ≤ 50 ml/min (se avsnitt 4.2).
Dosage adjustments are required in adults, adolescents and children with CrCL ≤ 50 ml/min (see section 4.2).
Dospåse
Sachet
Dospělí
Adults
Dospělí a starší pacienti
Adults and elderly
Dospělí od 18 let
Adults 18 and over
Dospělí od 18 let, kteří mají nadváhu
Adults, aged 18 or over, who are overweight.
Dospělí pacienti
Adult patients
Dospělí ve věku 18 a více let
Adults 18 and over
Dosregim2
Dose regimen2
Dosrekommendationer för barn och ungdomar är baserade på farmakokinetisk modellering.
Dose recommendations for children and adolescents are based on PK modelling.
Dosschema för underhållsdosering:
Dose scheme for the maintenance dose:
Dosstyrka ceftazidim/avibaktam (mg)
Dosage strength ceftazidime/avibactam (mg)
Dostupné farmakodynamické a toxikologické údaje u zvířat prokázaly vylučování guanfacinu a jeho metabolitů do mléka (viz bod 5.3).
Available pharmacodynamic and toxicological data in animals have shown excretion of guanfacine and its metabolites in milk (see section 5.3).
Dovoljeno je bilo sočasno odmerjanje peroralnih kortikosteroidov, imunomodulatorjev, aminosalicilatov in antibiotikov in 75% bolnikov je nadaljevalo s sočasnim prejemanjem vsaj enega od teh zdravil.
Concomitant doses of oral corticosteroids, immunomodulators, aminosalicylates and antibiotics were permitted and 75% of patients continued to receive at least one of these medications.
došlo k prodloužení maximálního
There was an increase
DPP-4 е основният ензим, участващ в бързото разграждане на инкретин-хормоните, глюкагон-подобния пептид-1 (GLP-1) и GIP (глюкозозависим инсулинотропен полипептид), които се освобождават от червата и нивата им се увеличават в отговор на хранене.
DPP-4 is the principal enzyme involved in the rapid degradation of the incretin hormones, glucagon-like peptide-1 (GLP-1) and GIP (glucose- dependent insulinotropic polypeptide), which are released by the intestine and levels are increased in response to a meal.
Dr.-Boehringer-Gasse 5-11
Boehringer Ingelheim RCV GmbH & Co KG Dr.-Boehringer-Gasse 5-11
Dra i avrivningsfliken (eller klipp) vid pilen 
Find the pull-back notch (or cut) as shown by the arrow symbol .
Dra tillbaka nålen och skaka flaskan för att få en klar lösning.
Withdraw the needle and shake the vial to give a clear solution.
Drammensveien 147 B NO-0277 Oslo
Drammensveien 288 NO-0283 Oslo
Draxxin 100 mg/ml инжекционен разтвор за говеда tulathromycin
Draxxin 100 mg/ml solution for injection for cattle tulathromycin
Draxxin 100 mg/ml инжекционен разтвор за говеда, свине и овце
Draxxin 100 mg/ml solution for injection for cattle, pigs and sheep
Draxxin 100 mg/ml инжекционен разтвор за говеда, свине и овце
Draxxin 100 mg/ml solution for injection for cattle, pigs and sheep Tulathromycin
Draxxin 100 mg/ml инжекционен разтвор за говеда, свине и овце tulathromycin
Draxxin 100 mg/ml solution for injection for cattle, pigs and sheep tulathromycin
Draxxin 25 mg/ml инжекционен разтвор за свине
Draxxin 25 mg/ml solution for injection for pigs
Draxxin 25 mg/ml инжекционен разтвор за свине
Draxxin 25 mg/ml solution for injection for pigs Tulathromycin
Draxxin 25 mg/ml инжекционен разтвор за свине tulathromycin
Draxxin 25 mg/ml solution for injection for pigs tulathromycin
Draxxin е сравнен с тилмикозин или флорфеникол (други антибиотици), а в проучванията за профилактика — и с плацебо (сляпо лечение).
Draxxin was compared with tilmicosin or florfenicol (other antibiotics), and, in the prevention studies also with placebo (a dummy treatment).
Draxxin се използва за лечение на следните заболявания, причинени от бактерии, които са чувствителни към тулатромицин: респираторни заболявания при говеда (BRD), причинени от Mannheimia haemolytica, Pasteurella multocida, Histophilus somni и Mycoplasma bovis; инфекциозен кератоконюнктивит по говеда, причинен от Moraxella bovis; респираторни заболявания при свине (SRD), причинени от Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis и Bordetella bronchiseptica. ранни стадии на копитен гнилец при овце, причинен от Dichelobacter nodosus, изискващи системно лечение (лечение с лекарство, прилагано през устата или инжекционно).
Draxxin is used to treat the following diseases if they are caused by bacteria that are sensitive to tulathromycin: bovine respiratory disease (BRD) in cattle caused by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; infectious bovine keratoconjunctivitis (IBK) in cattle, an eye disease caused by Moraxella bovis; swine respiratory disease (SRD) in pigs caused by Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis and Bordetella bronchiseptica.
Draxxin трябва да се прилага само ако се очаква разболяване на прасетата до 2-3 дни.
Draxxin should only be used if pigs are expected to develop the disease within 2–3 days.
Draxxin трябва да се прилага само ако се очаква разболяване на свинете до 2-3 дни.
Draxxin should only be used if pigs are expected to develop the disease within 2–3 days.
Draxxin трябва да се прилага само, ако се очаква разболяване на прасетата до 2-3 дни.
Draxxin should only be used if pigs are expected to develop the disease within 2–3 days.
draženje oči, ambliopija
Eye irritation, amblyopia
DREHM Pharma g mbH Tel: + 43 1 879 524 516
DREHM Pharma GmbH Tel: + 43 1 879 524 516
DRESS се появява първоначално като грипоподобни симптоми и обрив по лицето, след това обширен обрив с висока температура, повишени нива на чернодробните ензими при изследване на кръвта, повишаване на един вид бели кръвни клетки (еозинофилия) и увеличени лимфни възли.
DRESS appears init ially as flu-like symptoms and a rash on the face then an extended rash with a high temperature, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes.
DRESS се проявява първоначално като грипоподобни симптоми с лицев обрив, последван от разрастване на обрива, висока температура, подуване на лимфните възли, повишени нива на чернодробните ензими, установени при кръвни тестове, и повишаване на броя на определен вид бели кръвни клетки (е oзинофилия).
DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia).
DRESS синдромът се характеризира с обрив, повишена температура, еозинофилия и системни усложнения (включително, но не само тежък обрив или обрив, придружен с висока температура, общо неразположение, умора, болки в мускулите или ставите, мехури, орални лезии, конюктивит, хепатити еозинофилия).
The DRESS syndrome is characterised by rash, fever, eosinophilia and systemic involvement (including, but not limited to, severe rash or rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, hepatitis and eosinophilia).
driska
Diarrhoea
driska,
Fever
Driska, mehko blato, bruhanje, otopelost in anoreksija so redki.
Diarrhoea, soft faeces, vomiting, dullness and anorexia have been observed with low frequency.
Driska, mehko blato, bruhanje, otopelost in anoreksija so redki.
Diarrhoea, soft faeces, vomiting, dullness, and anorexia were observed with low frequency.
Driska, mehko blato, bruhanje, otopelost, anoreksija in slinjenje so redki.
Diarrhoea, soft faeces, vomiting, dullness, anorexia and salivation were observed with low frequency.
Dronedaron
Dronedarone
Druga 2 primera (okrevanje po prekinitvi zdravljenja ni znano) sta bila nejasna zaradi sočasno prisotnega glavkoma.
The other 2 cases, (dechallenge unknown) were confounded by comorbidity of glaucoma.
Druga nesteroidna protivnetna zdravila, diuretiki, antikoagulanti, aminoglikozidni antibiotiki in snovi z visoko vezavo na beljakovine se lahko kompetitivno vežejo, kar lahko privede do toksičnih učinkov.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.